Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid cancer: treatment optimization for maximum clinical benefit
Head and Neck Tumors (HNT)(2023)
摘要
.
更多查看译文
关键词
thyroid cancer,radioiodine-refractory
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要